# Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors

> **NCT00060268** · PHASE1,PHASE2 · COMPLETED · sponsor: **Roswell Park Cancer Institute** · enrollment: 11 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** HPPH

## Key facts

- **NCT ID:** NCT00060268
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-01
- **Primary completion:** 2003-09
- **Final completion:** 2004-06
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2011-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00060268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00060268, "Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00060268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*